Jon Congleton's Net Worth

Jon Congleton's net worth is estimated to be at least $1,623,493.96 as of 07/26/2025. CoreStreet's estimation of Jon Congleton's net worth is based on their sale of stock and current holding of stock.

Jon Congleton is CEO at Mineralys Therapeutics Inc. Common Stock. They have executed at least 15 trades of stock as per SEC Form 4 filings. Their most recent trade was for 15,884 units of MLYS stock on 07/11/2025. Their biggest sale was on 07/11/2025 when they sold 15,884 units of Mineralys Therapeutics Inc. Common Stock stock for $230,476.84. They typically trade 3 times per year.

Total value of insider buys:
  • $208,407.50
Total value of insider sells:
  • $1,415,086.46
Most recent insider trade:
  • July 11, 2025

Jon Congleton's Insider Trading History

Mineralys Therapeutics Inc. Common StockTitleAmountPriceTypeTotal Value
July 11, 2025
CEO15,884$14.51Sell$230,476.84
April 11, 2025
CEO15,319$12.19Sell$186,738.61
Jan. 13, 2025
CEO18,333$9.06Sell$166,096.98
Oct. 11, 2024
CEO15,271$13.52Sell$206,463.92
July 11, 2024
CEO15,746$13.34Sell$210,051.64
June 14, 2024
CEO16,229$12.52Sell$203,187.08
June 12, 2024
CEO16,607$12.77Sell$212,071.39
Nov. 22, 2023
CEO4,250$5.97Buy$25,372.50
Sept. 6, 2023
CEO2,250$12.08Buy$27,180.00
Aug. 17, 2023
CEO2,250$12.10Buy$27,225.00
Aug. 11, 2023
CEO2,000$12.89Buy$25,780.00
Alpine Immune Sciences IncTitleAmountPriceTypeTotal Value
June 16, 2016
CEO5,000$3.87Buy$19,350.00
March 24, 2016
CEO5,000$4.22Buy$21,100.00
March 22, 2016
CEO5,000$4.38Buy$21,900.00
Dec. 11, 2015
CEO5,000$8.10Buy$40,500.00